CD4 and neoplasm: Depletion of CD4+ cells by treatment with anti-CD4 antibodies will also result in depletion of T helper cells and regulatory T cells, which are CD4+ and have been shown to suppress anti-tumour immunity (reviewed in Zou, 2006).